ID   ANKS6_RAT               Reviewed;         885 AA.
AC   P0C0T2; Q2VWC0; Q5BJL2;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2006, sequence version 2.
DT   24-JUL-2024, entry version 119.
DE   RecName: Full=Ankyrin repeat and SAM domain-containing protein 6;
DE   AltName: Full=Polycystic kidney disease protein 1;
DE   AltName: Full=SamCystin;
DE   AltName: Full=Sterile alpha motif domain-containing protein 6;
DE            Short=SAM domain-containing protein 6;
GN   Name=Anks6; Synonyms=Pkdr1, Samd6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, INVOLVEMENT IN
RP   CY, AND VARIANT CY TRP-823.
RC   STRAIN=Brown Norway; TISSUE=Kidney;
RX   PubMed=16207829; DOI=10.1681/asn.2005060601;
RA   Brown J.H., Bihoreau M.-T., Hoffmann S., Kranzlin B., Tychinskaya I.,
RA   Obermuller N., Podlich D., Boehn S.N., Kaisaki P.J., Megel N., Danoy P.,
RA   Copley R.R., Broxholme J., Witzgall R., Lathrop M., Gretz N., Gauguier D.;
RT   "Missense mutation in sterile alpha motif of novel protein SamCystin is
RT   associated with polycystic kidney disease in (cy/+) rat.";
RL   J. Am. Soc. Nephrol. 16:3517-3526(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 864-885.
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH BICC1, AND CHARACTERIZATION
RP   OF VARIANT CY TRP-823.
RX   PubMed=19324013; DOI=10.1016/j.bbrc.2009.03.113;
RA   Stagner E.E., Bouvrette D.J., Cheng J., Bryda E.C.;
RT   "The polycystic kidney disease-related proteins Bicc1 and SamCystin
RT   interact.";
RL   Biochem. Biophys. Res. Commun. 383:16-21(2009).
RN   [5]
RP   INTERACTION WITH INVS; NEK8 AND NPHP3, DOMAIN ANK REPEATS, HYDROXYLATION AT
RP   ASN-129, AND MUTAGENESIS OF ASN-129; ASN-209 AND GLN-433.
RX   PubMed=23793029; DOI=10.1038/ng.2681;
RA   Hoff S., Halbritter J., Epting D., Frank V., Nguyen T.M., van Reeuwijk J.,
RA   Boehlke C., Schell C., Yasunaga T., Helmstadter M., Mergen M., Filhol E.,
RA   Boldt K., Horn N., Ueffing M., Otto E.A., Eisenberger T., Elting M.W.,
RA   van Wijk J.A., Bockenhauer D., Sebire N.J., Rittig S., Vyberg M., Ring T.,
RA   Pohl M., Pape L., Neuhaus T.J., Elshakhs N.A., Koon S.J., Harris P.C.,
RA   Grahammer F., Huber T.B., Kuehn E.W., Kramer-Zucker A., Bolz H.J.,
RA   Roepman R., Saunier S., Walz G., Hildebrandt F., Bergmann C.,
RA   Lienkamp S.S.;
RT   "ANKS6 is a central component of a nephronophthisis module linking NEK8 to
RT   INVS and NPHP3.";
RL   Nat. Genet. 45:951-956(2013).
RN   [6]
RP   INTERACTION WITH ANKS3.
RX   PubMed=26188091; DOI=10.1016/j.bbrc.2015.07.063;
RA   Ramachandran H., Engel C., Mueller B., Dengjel J., Walz G., Yakulov T.A.;
RT   "Anks3 alters the sub-cellular localization of the Nek7 kinase.";
RL   Biochem. Biophys. Res. Commun. 464:901-907(2015).
RN   [7]
RP   INTERACTION WITH ANKS3.
RX   PubMed=25671767; DOI=10.1038/ki.2015.17;
RA   Yakulov T.A., Yasunaga T., Ramachandran H., Engel C., Mueller B., Hoff S.,
RA   Dengjel J., Lienkamp S.S., Walz G.;
RT   "Anks3 interacts with nephronophthisis proteins and is required for normal
RT   renal development.";
RL   Kidney Int. 87:1191-1200(2015).
RN   [8]
RP   INTERACTION WITH ANKS3, CHARACTERIZATION OF VARIANT CY TRP-823, AND SITE.
RX   PubMed=26327442; DOI=10.1371/journal.pone.0136781;
RA   Delestre L., Bakey Z., Prado C., Hoffmann S., Bihoreau M.T., Lelongt B.,
RA   Gauguier D.;
RT   "ANKS3 Co-Localises with ANKS6 in Mouse Renal Cilia and Is Associated with
RT   Vasopressin Signaling and Apoptosis In Vivo in Mice.";
RL   PLoS ONE 10:E0136781-E0136781(2015).
CC   -!- FUNCTION: Required for renal function. {ECO:0000269|PubMed:16207829}.
CC   -!- SUBUNIT: Homooligomer (PubMed:19324013). Central component of a complex
CC       containing at least ANKS6, INVS, NEK8 and NPHP3 (PubMed:23793029).
CC       ANKS6 may organize complex assembly by linking INVS and NPHP3 to NEK8
CC       and INVS may target the complex to the proximal ciliary axoneme
CC       (PubMed:23793029). Interacts (via SAM domain) with BICC1 (via KH
CC       domains) in an RNA-dependent manner (PubMed:19324013). Interacts (via
CC       SAM domain) with ANKS3 (via SAM domain) (PubMed:25671767,
CC       PubMed:26188091, PubMed:26327442). {ECO:0000269|PubMed:19324013,
CC       ECO:0000269|PubMed:23793029, ECO:0000269|PubMed:25671767,
CC       ECO:0000269|PubMed:26188091, ECO:0000269|PubMed:26327442}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium
CC       {ECO:0000250|UniProtKB:Q6GQX6}. Cytoplasm
CC       {ECO:0000269|PubMed:19324013}. Note=Localizes to the proximal region of
CC       the primary cilium in the presence of INVS.
CC       {ECO:0000250|UniProtKB:Q6GQX6}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with moderate level in brain,
CC       skeletal muscle and testis. Expressed in renal tubules.
CC       {ECO:0000269|PubMed:16207829}.
CC   -!- DOMAIN: The ankyrin repeats are necessary and sufficient for NEK8-
CC       binding. {ECO:0000269|PubMed:23793029}.
CC   -!- PTM: Hydroxylated at Asn-129, most probably by HIF1AN. This
CC       hydroxylation results in decreased NEK8-binding.
CC       {ECO:0000269|PubMed:23793029}.
CC   -!- DISEASE: Note=Defects in Anks6 are the cause of polycystic kidney
CC       disease (cy). Heterozygous cy rats are characterized by progressive
CC       formation and enlargement of cysts in kidneys.
CC       {ECO:0000269|PubMed:16207829, ECO:0000269|PubMed:19324013,
CC       ECO:0000269|PubMed:26327442}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH91436.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY661303; AAT76432.1; -; mRNA.
DR   EMBL; AABR03040311; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC091436; AAH91436.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_001015028.2; NM_001015028.2.
DR   AlphaFoldDB; P0C0T2; -.
DR   SMR; P0C0T2; -.
DR   CORUM; P0C0T2; -.
DR   STRING; 10116.ENSRNOP00000056754; -.
DR   PhosphoSitePlus; P0C0T2; -.
DR   PaxDb; 10116-ENSRNOP00000056754; -.
DR   GeneID; 362515; -.
DR   KEGG; rno:362515; -.
DR   UCSC; RGD:3334; rat.
DR   AGR; RGD:3334; -.
DR   CTD; 203286; -.
DR   RGD; 3334; Anks6.
DR   eggNOG; KOG0504; Eukaryota.
DR   eggNOG; KOG4374; Eukaryota.
DR   InParanoid; P0C0T2; -.
DR   OrthoDB; 3179690at2759; -.
DR   PhylomeDB; P0C0T2; -.
DR   TreeFam; TF328552; -.
DR   PRO; PR:P0C0T2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0097543; C:ciliary inversin compartment; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0007368; P:determination of left/right symmetry; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   CDD; cd09518; SAM_ANKS6; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 3.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1.
DR   InterPro; IPR051631; Ankyrin-KH/SAM_domain.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR23206:SF1; ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 17; 1.
DR   PANTHER; PTHR23206; MASK PROTEIN; 1.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 3.
DR   Pfam; PF00536; SAM_1; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 10.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 2.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 7.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Cell projection; Cilium; Cytoplasm; Disease variant;
KW   Hydroxylation; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..885
FT                   /note="Ankyrin repeat and SAM domain-containing protein 6"
FT                   /id="PRO_0000067067"
FT   REPEAT          8..37
FT                   /note="ANK 1"
FT   REPEAT          68..97
FT                   /note="ANK 2"
FT   REPEAT          101..130
FT                   /note="ANK 3"
FT   REPEAT          134..163
FT                   /note="ANK 4"
FT   REPEAT          181..210
FT                   /note="ANK 5"
FT   REPEAT          215..244
FT                   /note="ANK 6"
FT   REPEAT          282..312
FT                   /note="ANK 7"
FT   REPEAT          316..345
FT                   /note="ANK 8"
FT   REPEAT          350..379
FT                   /note="ANK 9"
FT   REPEAT          383..414
FT                   /note="ANK 10"
FT   DOMAIN          773..836
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   REGION          415..439
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          491..522
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          563..775
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          855..885
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        609..636
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        695..775
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            823
FT                   /note="Essential for ANKS3 interaction"
FT                   /evidence="ECO:0000269|PubMed:26327442"
FT   MOD_RES         129
FT                   /note="3-hydroxyasparagine"
FT                   /evidence="ECO:0000269|PubMed:23793029"
FT   MOD_RES         650
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68DC2"
FT   MOD_RES         734
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68DC2"
FT   MOD_RES         742
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68DC2"
FT   VARIANT         823
FT                   /note="R -> W (in cy; loss of ability to self-associate,
FT                   does not affect interaction with Bicc1; loss of interaction
FT                   with ANKS3)"
FT                   /evidence="ECO:0000269|PubMed:16207829,
FT                   ECO:0000269|PubMed:19324013, ECO:0000269|PubMed:26327442"
FT   MUTAGEN         129
FT                   /note="N->A: Decreased NEK8-binding, but no effect on INVS-
FT                   binding; when associated with A-209."
FT                   /evidence="ECO:0000269|PubMed:23793029"
FT   MUTAGEN         209
FT                   /note="N->A: Decreased NEK8-binding, but no effect on INVS-
FT                   binding; when associated with A-129."
FT                   /evidence="ECO:0000269|PubMed:23793029"
FT   MUTAGEN         433
FT                   /note="Q->R: No effect on interaction with INVS, NEK8 AND
FT                   NPHP3, nor on ciliary localization. Unable to rescue ANKS6
FT                   knockout in a heterologous system."
FT                   /evidence="ECO:0000269|PubMed:23793029"
FT   CONFLICT        870
FT                   /note="C -> S (in Ref. 1; AAT76432 and 3; AAH91436)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   885 AA;  93809 MW;  B4F91C5DFCD2D35E CRC64;
     MGEGALAPGL QLLLRACEQG DTDTARRLLE PGGEPVAGSE AGAEPAGPEA ARAVEAGTPV
     PVDCSDEAGN SALQLAAAGG HEPLVRFLLR RGASVNSRNH YGWSALMQAA RCGHASVAHL
     LLDHGADVNA QNRLGASVLT VASRGGHLGV VKLLLEAGAT VDHRNPSGES TASGGSRDEL
     LGITALMAAV QHGHEAVVRL LMEWGADPNH TARTVGWSPL MLAALLGKLS VVQQLVEKGA
     NPDHLGVLEK TAFEVALDRK HRDLADYLDP LTTVRPKTDE EKRRPDIFHA LKMGNFQLVK
     EIADEDPNHV NLVNGDGATP LMLAAVTGQL PLVQLLVEKH ADMNKQDSVH GWTALMQATY
     HGNKEIVKYL LNQGADVTLR AKNGYTAFDL VMLLNDPDTE LVRLLASVCM QVNKDRGGRP
     SHRPPLPHSK ARQPWSIPML PDDKGGLKSW WSRMSNRFRK LKLMQTLPRG LAANQPLPFS
     DEPELALDST MRAPPQDRTN HLGPPEAAHA AKDSGPGNPR REKDDVLLTT MLRNGAPFPR
     LPSDKLKAVI PPFLPPSSFE LWSSDRSRTC PNGKADPMKT VLPPRASRAH PVGCVGTDGA
     AGRPVKFPSI SRSPTSPASS GNFNHSPHSS GGASGVGSMS RLGGELHNRS GGSVDSVLSQ
     IAAQRKKAAG LCEQKPPCQQ SSPVGPATGS SPPELPASLL GSGSGSSNVT SSSKKLDPGK
     RPPSGTSATS KSTSPTLTPS PSPKGHTAES SVSSSSSHRQ SKSSGGSSSG TITDEDELTG
     ILKKLSLEKY QPIFEEQEVD MEAFLTLTDG DLQELGIKTD GSRQQILAAI SELNAGKGRE
     RQILQETIHN FHSSFESSAS NTRAPGNSPC MAGWVRPEET VSSRR
//
